After a long series of delays, it seems the first trial in the federal drug adulteration and misbranding case may now come sometime in January 2022, per a status conference held on Sept. 15. Attorneys and defendants gathered both in person in the Southern District of New York and telephonically to coordinate scheduling for the […]
The post First Trial In Federal Drug Misbranding Case Will Likely Come In January appeared first on Horse Racing News | Paulick Report.